The burden of diabetic retinopathy-related blindness and visual impairment in the global labor force from 1990 to 2021 and projections to 2050: Analysis based on the 2021 global burden of disease study.

内容摘要

Diabetic retinopathy (DR) is a major microvascular complication of diabetes and is the leading cause of blindness and visual impairment among working-age populations worldwide. The loss of vision caused by diabetes significantly reduces the quality of life and has a major impact on the overall burden of visual impairment. This study assessed the global burden of blindness and visual impairment caused by diabetes among the working population from 1990 to 2021, and predicted the future trends in 2050. Based on data from the Global Burden of Disease Study 2021, we analyzed trends from 1990 to 2021 in the burden of diabetes-related blindness and visual impairment. Key metrics included case numbers and rates of prevalence and years lived with disability (YLDs). Decomposition analysis identified drivers of burden changes, and health inequality analysis assessed disparities by socioeconomic status. We used ARIMA and exponential smoothing models to forecast prevalence and YLDs from 2022 to 2050. From 1990 to 2021, the global burden of blindness and visual impairment caused by diabetes among the working population significantly increased.From 1990 to 2021, the global burden of blindness and visual impairment caused by diabetes among the working population significantly increased. Comparative analysis shows that the number of cases of type 2 diabetes and the number of YLDs are much higher than those of type 1 diabetes. Moreover, the burden on women has always been higher than that on men. Among the working population, blindness and visual impairments caused by diabetes pose a serious and increasingly severe public health threat worldwide, with the impact on women being particularly significant.Among the working population, blindness and visual impairments caused by diabetes pose a serious and increasingly severe public health threat worldwide, with the impact on women being particularly significant. Therefore, urgent action is needed to raise awareness of diabetic retinopathy among both clinicians and the general public, improve the level of early detection and treatment, reduce preventable vision loss, and alleviate the impact on family life and social economic burden caused by this decline in quality of life. Therefore, urgent action is needed to raise awareness of diabetic retinopathy among both clinicians and the general public, improve the level of early detection and treatment, reduce preventable vision loss, and alleviate the impact on family life and social economic burden resulting from this decline in quality of life.